Withdrawal of statins and risk of subarachnoid hemorrhage
BACKGROUND AND PURPOSE-: Vascular endothelium, which can be affected by statins, is believed to play a substantial role in subarachnoid hemorrhage (SAH). Our objective was to estimate the association between use and withdrawal of statins and the risk of SAH. METHODS-: We conducted a population-based case-control study within the PHARMO database. A case was defined as a person hospitalized for SAH (ICD-9-CM code 430) in the period January 1, 1998 to December 31, 2006. Ten randomly chosen controls were matched to each case on age, gender, and calendar date. RESULTS-: During the study period 1004 incident cases of SAH were identified. Current use of statins did not significantly decrease the risk of SAH (OR=0.77, 95% CI 0.55 to 1.07). The odds ratio for recent withdrawal compared to nonusers was 1.62 (95% CI 0.96 to 2.73). Compared to current use, recent withdrawal was associated with an increased risk of SAH (OR=2.34, 95% CI 1.35 to 4.05). Interaction analysis showed that the effect of statin withdrawal was highest in patients who had also recently stopped antihypertensive drugs (OR=6.77, 95% CI 2.10 to 21.8). CONCLUSIONS-: Current use of statins seems to lower the risk of SAH, although the reduction was not significant in new users. Statin withdrawal increased the risk of SAH by a factor 2, even more in patients who had also recently stopped their antihypertensive treatment.
|Keywords||3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, Case control study, Statins, Subarachnoid hemorrhage, Withdrawal|
|Persistent URL||dx.doi.org/10.1161/STROKEAHA.109.552760, hdl.handle.net/1765/25293|
Risselada, R., Straatman, H., van Kooten, F., Dippel, D.W.J., van der Lugt, A., Niessen, W.J., … Sturkenboom, M.C.J.M.. (2009). Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke, 40(8), 2887–2892. doi:10.1161/STROKEAHA.109.552760